CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Bayer Seeks Kerendia Label Expansion in Non-Diabetic CKD

RegulatoryKerendiaPositive
AI Analysis

Summary

Bayer is seeking a label expansion for Kerendia in non-diabetic chronic kidney disease. The article provides minimal details about the regulatory timeline or clinical data supporting the expansion.

Importance:5/10
Sentiment:
0.30
label_expansionchronic_kidney_diseaseregulatory
Related Companies

Read the original article

Published by yahoo_finance on October 8, 2026 3:21 PM

Read Original